Circulating soluble urokinase plasminogen receptor is reduced by - and predicts early treatment response to therapeutic plasma exchange in septic shock

for the BonHanZA (Bonn-Hannover-Zurich ARDS) Study Group

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Article number154927
JournalJournal of Critical Care
Volume85
DOIs
StatePublished - Feb 2025

Keywords

  • Biomarker
  • Extracorporeal treatment
  • Plasmapheresis
  • Precision medicine
  • Sepsis
  • Soluble urokinase plasminogen receptor

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this